The spectrum of MOG autoantibody-associated demyelinating diseases - Test2 - elhamkhani - TriplyDB

The spectrum of MOG autoantibody-associated demyelinating diseases

The spectrum of MOG autoantibody-associated demyelinating diseases

http://www.wikidata.org/entity/Q28293355

about

'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook Aquaporin-4 autoimmunity Treatment of neuromyelitis optica: state-of-the-art and emerging therapies Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort Histopathology and clinical course of MOG-antibody-associated encephalomyelitis Antibody biomarkers in CNS demyelinating diseases - a long and winding road Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome Thalamus pathology in multiple sclerosis: from biology to clinical application.Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.A complex role of herpes viruses in the disease process of multiple sclerosis.White matter changes in childhood NMDA receptor encephalitis: Bringing new light to an old phenotype Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.NMDA receptor antibodies associated with distinct white matter syndromes.Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report.MOG antibody-associated diseases Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

P2860

Q22000623-CDB5430C-77F7-43BC-ADDE-2D79884B949E Q26748229-49D51B60-C15D-45B8-BB70-1E09D1214F94 Q26786089-28E86800-919F-422B-A82D-44E5D7EF19CA Q26799559-73FF3620-2C8D-4EF9-87FF-29B9E9DAAE5F Q28245749-A151482F-5709-49A7-92D5-E5DD56571AE3 Q28256650-403E366C-3576-451D-8D1A-561A873C4699 Q28259551-0D8486F2-FC48-4CF9-A6C8-74967531E697 Q28262403-8959E99D-D876-492F-B182-654CDDEC67DA Q29010429-D4B145AE-93D0-4859-AA93-7522F73B9257 Q29036090-90997276-692E-48DE-B8EA-E904B26009B2 Q30371412-AE35DA35-12FB-4D4D-898D-9492D3D1745C Q30871067-3491CEAA-3957-4334-873E-1469119FE1D5 Q33591024-A346D1A5-147B-4AFA-B163-573195F4333E Q33645795-120229B1-0AC1-45FE-AC01-EA66E8414525 Q33770508-A8BC43C5-5A56-438F-AF7B-19496EF66997 Q34026880-1B115472-E66F-4B5F-ABD1-1AB08418CAFB Q34078589-A4A57E96-6CD5-4C48-9B1F-99E6031179EB Q34368543-E8B822EE-E210-4C71-8D00-0634E08389C8 Q34368609-C0475E24-CAB7-4BD3-A81E-EFBE0808CF7A Q34368624-0762BDD0-BB0B-4905-89D8-073D1A9A64A0 Q34431835-14252CE1-0DF8-42A7-9562-609E808F95A5 Q34453889-E5A51445-64D0-4C78-91A8-C6615A9FFA44 Q34486841-D88E22A1-9CD6-4488-BE43-AF1EEECC1A4E Q34513731-425B1935-783B-4175-A3A9-A862D425593F Q34636918-78DDF254-AC5F-47F3-8A4C-60F25B347D92 Q35023345-72F4511E-2D96-4ADD-A691-F7BF49F8D030 Q35052199-A134EB0E-FC8D-4169-AF08-FAF17BF77A36 Q35179839-B8D7D587-D964-4743-AC34-0BB241EA4C5F Q35208069-20057F1E-8759-4560-B021-AACCC23C3A5D Q35208073-C1737A72-E6DE-49DB-B7E4-4A61A225E1AF Q35211076-E695DBFC-F518-42F5-96D3-41F1F11001CF Q35228937-23805FBA-4025-4CC9-9AE2-8177A9B30032 Q35589347-26C5722A-56D3-4616-9F7D-BD42E37C0EB9 Q35609259-68BCABBB-AD42-4066-9D06-4242003C21B9 Q35674246-B051CF57-0F97-4B04-8BEA-31B7082FD079 Q35833865-FE9CDE30-8B4C-4998-B475-7D816112B6A0 Q35840053-61E29866-799A-49EE-A6B4-6D713B41FF33 Q35937581-A86C37FD-4278-45F5-8C56-DCDE9AD88075 Q36078270-21ABE93F-AD63-4288-B96E-9F83141A006A Q36170912-8D7AD858-FA70-43BC-BE43-0967366DB78A

P2860

The spectrum of MOG autoantibody-associated demyelinating diseases

http://www.wikidata.org/entity/Q28293355

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The spectrum of MOG autoantibody-associated demyelinating diseases

@ast

The spectrum of MOG autoantibody-associated demyelinating diseases

@en

The spectrum of MOG autoantibody-associated demyelinating diseases

@nl

type

label

The spectrum of MOG autoantibody-associated demyelinating diseases

@ast

The spectrum of MOG autoantibody-associated demyelinating diseases

@en

The spectrum of MOG autoantibody-associated demyelinating diseases

@nl

prefLabel

The spectrum of MOG autoantibody-associated demyelinating diseases

@ast

The spectrum of MOG autoantibody-associated demyelinating diseases

@en

The spectrum of MOG autoantibody-associated demyelinating diseases

@nl

P1433

Q28293355-E2ACB1D6-A4A0-4551-B50F-025E7974DC8C

P1476

Q28293355-EA7CD553-69D3-4871-A178-808C135A3FB5

P2093

Q28293355-0AE6E972-D254-4FC0-8D31-1985BFF2D51D

Q28293355-24026C68-3CB5-4581-AF73-4A40030294D7

Q28293355-C432FB6A-85C7-4D0D-A40B-0A6062B40E01

Q28293355-F2C81A31-D9F6-4A29-93EC-EA77FDF3EE8F

P2860

Q28293355-01A9B6FF-504B-42F3-84FD-A985BA327D3F

Q28293355-19816CD8-41DD-43D9-A4A1-A00E50BA7B7B

Q28293355-1A0B7E16-8A8B-400D-A7A7-2A7C61D32ACE

Q28293355-21EAF428-4D62-4421-843A-A73B25D10174

Q28293355-251042C3-E07D-4663-BA40-286EBA06F368

Q28293355-26F8A8A8-64E5-4A59-B2C0-D46466468B56

Q28293355-2B3D194D-4B4F-45CE-9F23-56602A62011D

Q28293355-3F29EF5B-E6F8-41C7-80A2-85C602B094B4

Q28293355-3FDE0383-63B6-4620-9B3A-08039B0947DE

Q28293355-4871D4B9-286A-4EB6-BEDC-6C2BAC44ABFB

P2888

Q28293355-F1F6FE7C-A577-4015-B939-800AA598F902

P304

Q28293355-24CBDCB7-4720-4C92-BADC-8E3E80D9E59D

P31

Q28293355-92619AE6-98F7-4053-AF55-D284A6F19303

P3181

Q28293355-0D1B4D05-5F49-4FE9-8211-F2D4E60997F7

P356

Q28293355-09174590-E250-4A23-B065-7D1F7D8BC176

P407

Q28293355-CD7CFBBD-60F3-4321-9403-4600E51A5E7E

P433

Q28293355-9E4041FA-3580-4FED-861C-F428156BF9D7

P478

Q28293355-F38033EE-61CD-407B-915F-964557EF42CC

P577

Q28293355-5551B288-266F-4C8A-AD2C-0313019718C0

P6179

Q28293355-E9BE00A7-70B1-49E0-8287-E16FDEF4809F

P698

Q28293355-C6BF1A21-707B-4446-A7E6-35CDC4E87899

P921

Q28293355-0C76A3A6-8259-4B3D-8C02-122DAF06E0DB

P3181

P356

NRNEUROL.2013.118

P1433

Nature Reviews Neurology

P1476

The spectrum of MOG autoantibody-associated demyelinating diseases

@en

P2093

Franziska Di Pauli

http://www.w3.org/2001/XMLSchema#string

Kevin Rostásy

http://www.w3.org/2001/XMLSchema#string

Markus Reindl

http://www.w3.org/2001/XMLSchema#string

Thomas Berger

http://www.w3.org/2001/XMLSchema#string

P2860

Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

Characterization and expression of the cDNA coding for the human myelin/oligodendrocyte glycoprotein

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

Multiple sclerosis

Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Acute Disseminated Encephalomyelitis: Current Understanding and Controversies

MS and the B cell controversy.

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis

P2888

nrneurol.2013.118

P304

455-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

289133

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRNEUROL.2013.118

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005394477

http://www.w3.org/2001/XMLSchema#string

P698

23797245

http://www.w3.org/2001/XMLSchema#string

P921